TABLE 3.
Death and neurodevelopmental impairment or disability at 18-mo corrected age
| Characteristic | HMBF no./total (%) | BMBF no./total (%) | OR (95% CI)1 | P value |
|---|---|---|---|---|
| Death and neurodevelopmental impairment (death or composite score <85, hearing or visual impairment, or cerebral palsy) | ||||
| Cognitive | 15/62 (24.2) | 12/54 (22.2) | 1.3 (0.5, 3.2) | 0.61 |
| Language | 22/61 (36.1) | 21/52 (40.4) | 0.9 (0.4, 2.0) | 0.75 |
| Motor | 14/61 (23.0) | 12/54 (22.2) | 1.2 (0.5, 3.0) | 0.71 |
| Death and neurodevelopmental disability (death or composite score <70, hearing or visual impairment, or cerebral palsy) | ||||
| Cognitive | 9/62 (14.5) | 9/54 (16.7) | 1.0 (0.3, 2.9) | 0.98 |
| Language | 12/61 (19.7) | 11/52 (21.2) | 1.0 (0.4, 2.8) | 0.92 |
| Motor | 8/61 (13.1) | 10/54 (18.5) | 0.7 (0.3, 2.1) | 0.54 |
1
Logistic regression analyses of the proportions of participants with scores indicative of neuroimpairment or disability were adjusted only for birth weight strata and sex due to limited sample size.
BMBF, bovine milk-based fortifier group; HMBF, human milk-based fortifier group.